European Diabetes Therapeutics Market

European Diabetes Therapeutics Market - How Far Would it Go:New Classes of Drugs to Emerge by 2014
Share this:
     
Published: 11 Sep 2011

The research study aims to thoroughly assess and analyse the diabetes therapeutics market, market and technology trends, in European countries and provide strategic recommendations for the success of the market participants. Diabetes is the fastest growing market in the pharmaceutical industry. This study is focussed on two segments Insulin and Non-Insulin. The insulin market is dominated by modern insulins and analogues. New therapeutic classes of drugs are a major contributor in the Non-Insulin segment.

  1.  
  2.  
  3.  
  4.  
  5.  
  6.  
  7.  
  8.  
  9.  
  10.  
  11.  

Tools

Features of this research

SUBSCRIPTIONS

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..